Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for O60825

Entry ID Method Resolution Chain Position Source
5HTK X-ray 201 A A/B 1-505 PDB
AF-O60825-F1 Predicted AlphaFoldDB

318 variants for O60825

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1333052850
CA344500237
3 G>E No ClinGen
TOPMed
CA1366673
rs747575332
6 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA344500329
rs1258742601
9 Q>K No ClinGen
gnomAD
CA1366674
rs757523612
11 N>D No ClinGen
ExAC
gnomAD
rs147250602
CA1366675
12 N>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA344500411
rs1253911170
12 N>S No ClinGen
gnomAD
rs1377504147
CA344500449
14 Y>C No ClinGen
TOPMed
rs1381561045
CA344500489
16 T>N No ClinGen
gnomAD
TCGA novel 19 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1572715668
CA344500563
21 L>V No ClinGen
Ensembl
rs868372519
CA36595437
22 R>* No ClinGen
TOPMed
rs541295353
CA344500588
22 R>P No ClinGen
gnomAD
CA36595458
rs541295353
22 R>Q No ClinGen
gnomAD
rs774949798
CA1366678
23 M>T No ClinGen
ExAC
gnomAD
rs1462660383
CA344500638
25 E>D No ClinGen
gnomAD
CA344500659
rs1326125807
27 K>Q No ClinGen
gnomAD
TCGA novel 28 C>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA344500698
rs1558056631
29 S>P No ClinGen
Ensembl
rs879360833
CA36602602
32 S>F No ClinGen
Ensembl
CA36602600
rs904063457
32 S>P No ClinGen
TOPMed
rs757817373
CA1366693
34 M>V No ClinGen
ExAC
gnomAD
rs372621164
CA1366694
38 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
COSM1261974
CA344502218
rs1440501295
39 T>I oesophagus [Cosmic] No ClinGen
cosmic curated
TOPMed
CA1366697
rs779520683
42 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs767982799
CA1366699
43 M>R No ClinGen
ExAC
TOPMed
gnomAD
CA1366698
rs748997601
43 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1342661237
CA344502268
47 P>L No ClinGen
TOPMed
rs778496226
CA1366700
48 A>V No ClinGen
ExAC
gnomAD
rs1054562775
CA36602638
49 R>Q No ClinGen
TOPMed
gnomAD
rs377086278
CA1366701
49 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1203971874
CA344502302
53 Y>F No ClinGen
gnomAD
CA1366703
rs142450533
54 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA344502335
rs1359217225
58 L>R No ClinGen
TOPMed
CA344502346
rs1335499341
COSM1338374
COSM1338375
60 R>C large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA344502347
rs1416621970
60 R>H No ClinGen
TOPMed
rs770872328
CA1366705
61 Y>C No ClinGen
ExAC
gnomAD
rs775535860
CA1366706
63 N>K No ClinGen
ExAC
TOPMed
gnomAD
CA344502363
rs1471577175
63 N>Y No ClinGen
gnomAD
CA1366708
rs764023717
64 W>* No ClinGen
ExAC
gnomAD
CA1366709
rs751726239
65 I>F No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 67 V>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA344502396
rs1420545915
68 P>T No ClinGen
TOPMed
TCGA novel 70 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 72 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs761181176
CA1366731
76 V>A No ClinGen
ExAC
gnomAD
CA344502463
rs1310257702
76 V>L No ClinGen
TOPMed
TCGA novel 78 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM1338377
COSM1338376
rs766636539
CA1366732
78 R>W Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TCGA novel 79 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1274763372
CA344502482
79 R>H No ClinGen
gnomAD
rs1374736166
CA344502484
80 E>K No ClinGen
TOPMed
CA344502517
rs1343576153
84 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs754298949
CA1366733
85 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA344502528
rs1360704563
86 K>T No ClinGen
TOPMed
rs754558885
CA1366734
88 Y>C No ClinGen
ExAC
gnomAD
rs752423669
CA1366736
89 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA1366738
rs150442637
92 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs757942412
CA1366737
92 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA344502574
rs1375859166
93 H>P No ClinGen
gnomAD
CA1366739
rs746887791
93 H>Y No ClinGen
ExAC
gnomAD
CA344502605
rs1471124270
97 E>K No ClinGen
gnomAD
CA1366740
rs757278586
102 R>C No ClinGen
ExAC
gnomAD
CA344502645
rs1407010150
102 R>P No ClinGen
gnomAD
CA36603007
rs886928075
105 C>R No ClinGen
Ensembl
CA344502866
rs1338544888
106 A>S No ClinGen
TOPMed
CA1366759
rs138596532
109 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA36603029
rs1008121368
112 D>A No ClinGen
Ensembl
rs779834380
CA1366762
115 A>S No ClinGen
ExAC
gnomAD
rs544901755
CA1366763
115 A>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA344503001
rs1355637462
116 Y>H No ClinGen
gnomAD
CA344503019
rs1243644149
117 L>V No ClinGen
gnomAD
CA344503033
rs1263124107
118 T>A No ClinGen
gnomAD
CA36603043
rs996824433
120 E>D No ClinGen
TOPMed
rs747164858
CA344503061
120 E>K No ClinGen
ExAC
gnomAD
rs747164858
CA1366766
120 E>Q No ClinGen
ExAC
gnomAD
CA344503103
rs1273810034
122 G>D No ClinGen
gnomAD
rs777159575
CA1366768
125 A>E No ClinGen
ExAC
TOPMed
gnomAD
CA344503143
rs1482035051
125 A>T No ClinGen
gnomAD
rs777159575
CA1366769
125 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA344503200
rs1572725190
126 V>M No ClinGen
Ensembl
rs1558060991
CA344503241
128 D>G No ClinGen
Ensembl
CA1366783
rs758599692
131 N>D No ClinGen
ExAC
TOPMed
gnomAD
CA344503295
rs1373794346
132 T>I No ClinGen
gnomAD
rs141264336
CA1366784
133 T>I No ClinGen
1000Genomes
ESP
ExAC
gnomAD
CA344503300
rs1440663894
133 T>S No ClinGen
TOPMed
CA1366786
rs770977759
134 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA1366785
rs747230857
134 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA344503316
rs1417065403
135 E>* No ClinGen
TOPMed
CA36603115
rs926826045
139 M>V No ClinGen
gnomAD
rs770491946
CA1366789
142 N>I No ClinGen
ExAC
gnomAD
CA1366790
rs775973822
143 F>C No ClinGen
ExAC
gnomAD
CA344503418
rs1319252635
143 F>V No ClinGen
gnomAD
rs1311597516
CA344503455
146 Q>E No ClinGen
gnomAD
rs1254341406
CA344503560
151 V>L No ClinGen
TOPMed
CA1366810
rs146105658
153 F>Y No ClinGen
1000Genomes
ExAC
gnomAD
CA1366812
rs774632326
157 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs775487245
CA1366813
159 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA344503671
rs1199781244
160 D>G No ClinGen
TOPMed
CA1366814
rs771660113
160 D>N No ClinGen
ExAC
gnomAD
CA344503696
rs1473113856
162 D>G No ClinGen
gnomAD
rs1181992971
CA344503719
164 I>T No ClinGen
gnomAD
CA344503726
rs1572725775
165 A>P No ClinGen
Ensembl
CA1366816
rs772759643
168 I>N No ClinGen
ExAC
gnomAD
rs1572727371
CA344503914
171 V>G No ClinGen
Ensembl
CA344503936
rs1373908319
173 V>L No ClinGen
TOPMed
rs960699790
CA36603744
176 P>L No ClinGen
Ensembl
rs1226607777
CA344503993
178 Y>H No ClinGen
gnomAD
CA344504039
rs770374061
181 R>S No ClinGen
ExAC
gnomAD
TCGA novel 184 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1366838
rs759466201
185 N>D No ClinGen
ExAC
gnomAD
CA1366840
rs368390449
186 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs762614324
CA1366841
187 M>I No ClinGen
ExAC
gnomAD
CA344504111
rs1482075257
CA344504115
187 M>L No ClinGen
gnomAD
TCGA novel 188 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA344504616
rs1303409294
193 R>K No ClinGen
TOPMed
rs1558061951
CA344504646
194 I>M No ClinGen
Ensembl
rs756462878
CA344504643
194 I>S No ClinGen
ExAC
TOPMed
gnomAD
rs756462878
CA1366844
194 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA344504663
rs1333386085
195 E>V No ClinGen
TOPMed
CA1366846
rs754007770
198 K>R No ClinGen
ExAC
gnomAD
CA344504833
rs1446115288
201 Y>* No ClinGen
gnomAD
rs755485099
CA1366847
201 Y>H No ClinGen
ExAC
gnomAD
rs779242193
CA1366848
202 R>* No ClinGen
ExAC
gnomAD
CA1366849
rs142943270
202 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1211043109
CA344504849
203 P>T No ClinGen
TOPMed
gnomAD
CA344505000
rs1347830773
209 Y>C No ClinGen
TOPMed
gnomAD
rs1296032607
CA344504989
209 Y>N No ClinGen
gnomAD
rs1300138985
CA344505024
210 D>G No ClinGen
TOPMed
rs758627461
CA1366850
210 D>N No ClinGen
ExAC
gnomAD
rs908070137
CA36603782
211 K>R No ClinGen
gnomAD
rs1456928197
CA344505689
213 L>F No ClinGen
gnomAD
rs1456928197
CA344505691
213 L>V No ClinGen
gnomAD
rs1156973953
CA344505709
214 S>F No ClinGen
gnomAD
rs756883233
CA1366874
215 F>C No ClinGen
ExAC
gnomAD
CA1366876
rs745521924
219 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs779669819
CA1366878
221 V>M No ClinGen
ExAC
gnomAD
CA1366879
rs749172793
222 G>S No ClinGen
ExAC
gnomAD
rs538947855
CA1366880
224 R>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1366881
rs369332885
224 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 226 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1366882
rs761650506
226 L>S No ClinGen
ExAC
gnomAD
CA1366884
rs776928187
228 N>S No ClinGen
ExAC
gnomAD
rs759818347
CA1366885
229 R>K No ClinGen
ExAC
gnomAD
rs759818347
CA36604657
229 R>T No ClinGen
ExAC
gnomAD
CA1366886
rs765219768
235 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA36604665
rs977149025
237 K>R No ClinGen
TOPMed
rs1335199848
CA344506119
242 L>F No ClinGen
TOPMed
TCGA novel 244 N>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 246 H>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs145329872
CA1366889
247 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA344506223
rs1403794766
248 Q>* No ClinGen
TOPMed
CA1366891
COSM1500722
rs371999507
COSM1500721
250 R>C lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 250 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs552310576
CA1366892
251 T>A No ClinGen
1000Genomes
ExAC
gnomAD
rs200517654
CA36604696
251 T>I No ClinGen
Ensembl
CA344506276
rs1156396766
252 I>V No ClinGen
TOPMed
CA344506294
rs1469193431
253 Y>D No ClinGen
TOPMed
CA1366897
rs754555677
256 R>Q No ClinGen
ExAC
gnomAD
rs374742937
CA1366896
256 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1366898
rs140730046
257 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA344506346
rs1558063174
257 H>Y No ClinGen
Ensembl
rs773199400
CA1366901
261 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 264 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770099007
CA1366903
265 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA344506486
rs1229096159
266 G>R No ClinGen
gnomAD
TCGA novel 267 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1273880584
CA344506555
270 G>D No ClinGen
gnomAD
rs1266166733
CA344506574
271 D>V No ClinGen
TOPMed
rs764192402
CA1366906
275 S>L No ClinGen
ExAC
TOPMed
gnomAD
CA36604742
rs1036369293
276 V>L No ClinGen
TOPMed
TCGA novel 277 R>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs149323408
CA1366910
277 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1366908
rs866843433
277 R>W No ClinGen
TOPMed
gnomAD
CA1366937
rs762272947
282 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA344506925
rs1484716265
283 Q>* No ClinGen
TOPMed
CA1366938
rs190698633
286 R>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1170424890
CA344506979
287 K>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1222627961
CA344507011
289 L>R No ClinGen
TOPMed
rs1360914842
CA344507042
291 E>D No ClinGen
TOPMed
rs773613236
CA1366939
291 E>K No ClinGen
ExAC
gnomAD
rs761058940
CA1366940
292 Q>K No ClinGen
ExAC
gnomAD
CA1366943
rs759321562
299 V>M No ClinGen
ExAC
CA344507161
rs1359350877
300 W>* No ClinGen
TOPMed
CA1366944
rs764836700
301 T>K No ClinGen
ExAC
gnomAD
rs1388475370
CA344507189
302 S>N No ClinGen
gnomAD
CA1366946
rs758392466
304 L>S No ClinGen
ExAC
gnomAD
rs1296821090
CA344507258
306 R>S No ClinGen
TOPMed
rs777720748
CA1366947
307 T>S No ClinGen
ExAC
TOPMed
gnomAD
rs1558063678
CA344507294
309 Q>H No ClinGen
Ensembl
rs1288454769
CA344507305
310 T>I No ClinGen
TOPMed
rs757012478
CA1366949
313 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs780905072
CA1366950
314 L>H No ClinGen
ExAC
TOPMed
gnomAD
rs1193398341
CA344507348
CA344507350
315 G>R No ClinGen
TOPMed
gnomAD
rs144563941
CA1366954
317 P>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs144563941
CA1366953
317 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA344507382
rs955937201
318 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs955937201
CA36604919
318 Y>F No ClinGen
TOPMed
rs1199623403
CA344507428
321 W>* No ClinGen
TOPMed
rs1413638777
CA344507426
321 W>L No ClinGen
gnomAD
CA344507420
rs1572731533
321 W>R No ClinGen
Ensembl
rs988844195
CA36604926
325 N>S No ClinGen
Ensembl
rs772075087
CA1366956
326 E>V No ClinGen
ExAC
gnomAD
TCGA novel 328 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1309582719
CA344507608
330 G>C No ClinGen
gnomAD
CA36605452
rs888235501
330 G>D No ClinGen
TOPMed
rs1309582719
CA344507607
330 G>R No ClinGen
gnomAD
CA344507622
rs1202457002
332 C>F No ClinGen
gnomAD
CA344507655
rs1409039570
336 T>I No ClinGen
gnomAD
TCGA novel 340 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs542543450
CA344507704
343 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs542543450
CA1366970
343 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs140764704
CA1366969
343 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs755925005
CA344507711
344 Y>* No ClinGen
ExAC
TOPMed
gnomAD
CA344507705
rs1185853060
344 Y>N No ClinGen
gnomAD
CA344507745
rs1313557767
349 A>S No ClinGen
TOPMed
gnomAD
CA344507746
rs1321600150
349 A>V No ClinGen
gnomAD
rs779065776
COSM1295796
COSM1295797
CA1366972
351 R>* Variant assessed as Somatic; 0.0 impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
COSM1583971
CA344507756
COSM903084
rs1483577508
351 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1204977075
CA344507759
352 D>N No ClinGen
gnomAD
CA344507782
rs1558064380
354 E>D No ClinGen
Ensembl
TCGA novel 358 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1230754698
CA344507813
359 R>* No ClinGen
gnomAD
rs900639002
CA36605467
359 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1311313688
CA344507828
361 P>L No ClinGen
TOPMed
CA344507834
rs1181890400
362 G>A No ClinGen
gnomAD
rs1558064819
CA344507877
367 Q>E No ClinGen
Ensembl
CA1366988
rs200235696
368 D>E No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 368 D>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1366499814
CA344507912
372 R>Q No ClinGen
gnomAD
rs755840336
CA1366989
372 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA1366991
rs752901360
374 E>G No ClinGen
ExAC
gnomAD
CA1366992
rs758615527
375 P>A No ClinGen
ExAC
gnomAD
CA1366994
rs761259786
382 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs761259786
CA36605758
382 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs1284455137
CA344507986
384 G>S No ClinGen
TOPMed
rs1215526354
CA344507997
385 N>S No ClinGen
TOPMed
rs1464080898
CA344508014
388 V>I No ClinGen
TOPMed
gnomAD
rs1226884383
CA344508029
390 S>C No ClinGen
TOPMed
rs776061783
CA1366999
391 H>Y No ClinGen
ExAC
gnomAD
CA1367000
rs748936668
392 Q>R No ClinGen
ExAC
gnomAD
CA1367001
rs768238400
394 V>I No ClinGen
ExAC
gnomAD
CA1367002
rs774072374
396 R>H No ClinGen
ExAC
gnomAD
rs771560698
CA36605799
400 A>D No ClinGen
Ensembl
CA1367004
rs767018388
401 Y>H No ClinGen
ExAC
gnomAD
rs1350532963
CA344508115
403 L>F No ClinGen
TOPMed
gnomAD
rs372658038
CA36605806
407 A>S No ClinGen
ESP
TOPMed
gnomAD
rs1236180052
CA344508159
408 D>V No ClinGen
gnomAD
CA1367027
rs760576080
409 E>Q No ClinGen
ExAC
gnomAD
CA1367028
rs770905601
411 P>S No ClinGen
ExAC
CA344508190
rs1339341066
413 L>W No ClinGen
TOPMed
rs183914038
CA1367029
415 C>Y No ClinGen
1000Genomes
ESP
ExAC
gnomAD
rs1289567140
CA344508212
416 P>L No ClinGen
gnomAD
CA344508221
rs1205695827
418 H>N No ClinGen
gnomAD
rs1248257163
CA344508234
419 T>I No ClinGen
gnomAD
CA36606120
rs921147631
420 I>N No ClinGen
gnomAD
CA344508239
rs921147631
420 I>T No ClinGen
gnomAD
CA36606121
rs146616886
422 K>R No ClinGen
ESP
TOPMed
CA344508645
rs1239250425
424 T>N No ClinGen
gnomAD
CA1367033
rs762186384
426 V>M No ClinGen
ExAC
gnomAD
rs531487877
CA1367034
428 Y>C No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 429 G>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA36606205
rs903496970
435 I>M No ClinGen
TOPMed
CA344508798
rs1402553375
435 I>V No ClinGen
gnomAD
CA1367049
rs769465082
436 K>Q No ClinGen
ExAC
gnomAD
rs767797359
CA1367052
446 R>S No ClinGen
ExAC
CA344508880
rs1435766225
447 D>V No ClinGen
gnomAD
CA36606236
rs113962276
449 P>S No ClinGen
TOPMed
gnomAD
rs113962276
CA344508893
449 P>T No ClinGen
TOPMed
gnomAD
rs760767079
CA1367054
450 T>A No ClinGen
ExAC
gnomAD
rs760767079
CA1367055
450 T>P No ClinGen
ExAC
gnomAD
CA344508981
rs1388237870
452 N>S No ClinGen
gnomAD
rs1233263364
CA344508999
453 F>S No ClinGen
TOPMed
CA1367069
rs769816758
455 K>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1320732890
CA344509040
456 N>T No ClinGen
TOPMed
rs1370680907
CA344509050
457 Q>K No ClinGen
gnomAD
CA344509074
rs1223098864
458 T>S No ClinGen
gnomAD
rs770522438
CA1367070
461 R>K No ClinGen
ExAC
TOPMed
gnomAD
rs1558066158
CA344509194
467 F>L No ClinGen
Ensembl
rs768572193
CA1367072
468 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs776811345
CA1367076
471 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA1367078
rs765728026
472 S>G No ClinGen
ExAC
gnomAD
CA1367079
rs151137785
472 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA344509263
rs147014775
473 S>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1367080
COSM1176977
rs147014775
473 S>L endometrium [Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs751201910
CA1367082
474 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs1361942650
CA344509275
474 N>T No ClinGen
gnomAD
rs757006012
CA1367083
476 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs780541078
CA1367084
477 R>G No ClinGen
ExAC
gnomAD
rs1301520570
CA344509313
477 R>K No ClinGen
TOPMed
gnomAD
rs745331127
CA1367085
477 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA1367086
rs755606905
478 R>C No ClinGen
ExAC
gnomAD
CA1367087
rs779972554
COSM1338385
478 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA344509324
rs779972554
478 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs1225863865
CA344509378
482 Y>C No ClinGen
TOPMed
CA36606601
rs377519008
482 Y>N No ClinGen
ESP
TOPMed
gnomAD
CA344509408
rs1176084070
484 V>A No ClinGen
gnomAD
CA344509402
rs1480767310
484 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA344509416
rs1247766351
485 G>R No ClinGen
gnomAD
rs1164119858
CA344509438
486 S>R No ClinGen
gnomAD
rs200699550
CA36606611
487 R>Q No ClinGen
1000Genomes
gnomAD
CA1367093
rs776741129
487 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA344509488
rs1170267853
491 P>S No ClinGen
gnomAD
CA344509527
rs1325338390
494 P>T No ClinGen
TOPMed
CA344509541
rs374972078
495 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA36606612
rs374972078
495 L>V No ClinGen
gnomAD
CA1367095
rs141454250
496 R>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1367096
rs538599971
COSM361437
496 R>H lung [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
rs538599971
CA344509555
496 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1367097
rs763511852
499 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA1367098
rs764441910
500 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA344509650
rs1395512411
503 G>A No ClinGen
TOPMed
CA1367099
rs751964694
503 G>R No ClinGen
ExAC
gnomAD
TCGA novel 504 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs757581201
CA1367100
504 A>V No ClinGen
ExAC
gnomAD
CA1367103
rs755589744
505 D>H No ClinGen
ExAC
TOPMed
gnomAD
CA1367104
rs755589744
505 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs755589744
CA344509670
505 D>Y No ClinGen
ExAC
TOPMed
gnomAD
rs377350701
CA1367106
506 D>S No ClinGen
ESP
ExAC
TOPMed
gnomAD

No associated diseases with O60825

5 regional properties for O60825

Type Name Position InterPro Accession
conserved_site Actinin-type actin-binding domain, conserved site 213 - 237 IPR001589
domain Calponin homology domain 124 - 241 IPR001715-1
domain Calponin homology domain 269 - 372 IPR001715-2
domain Calponin homology domain 393 - 499 IPR001715-3
domain Calponin homology domain 514 - 622 IPR001715-4

Functions

Description
EC Number 3.1.3.46 Phosphoric monoester hydrolases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.

4 GO annotations of molecular function

Name Definition
6-phosphofructo-2-kinase activity Catalysis of the reaction: beta-D-fructose 6-phosphate + ATP = beta-D-fructose 2,6-bisphosphate + ADP + 2 H(+).
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
fructose-2,6-bisphosphate 2-phosphatase activity Catalysis of the reaction: D-fructose 2,6-bisphosphate + H2O = D-fructose-6-phosphate + phosphate.
protein kinase binding Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.

8 GO annotations of biological process

Name Definition
fructose 2,6-bisphosphate metabolic process The chemical reactions and pathways involving fructose 2,6-bisphosphate. The D enantiomer is an important regulator of the glycolytic and gluconeogenic pathways. It inhibits fructose 1,6-bisphosphatase and activates phosphofructokinase.
fructose metabolic process The chemical reactions and pathways involving fructose, the ketohexose arabino-2-hexulose. Fructose exists in a open chain form or as a ring compound. D-fructose is the sweetest of the sugars and is found free in a large number of fruits and honey.
glucose catabolic process The chemical reactions and pathways resulting in the breakdown of glucose, the aldohexose gluco-hexose.
glycolytic process The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP and the reduction of NAD(P) to NAD(P)H. Glycolysis begins with the metabolism of a carbohydrate to generate products that can enter the pathway and ends with the production of pyruvate. Pyruvate may be converted to acetyl-coenzyme A, ethanol, lactate, or other small molecules.
lactate metabolic process The chemical reactions and pathways involving lactate, the anion of lactic acid.
positive regulation of glucokinase activity Any process that activates or increases the frequency, rate or extent of glucokinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a glucose molecule.
positive regulation of insulin secretion Any process that activates or increases the frequency, rate or extent of the regulated release of insulin.
response to glucose Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.

13 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P32604 FBP26 Fructose-2,6-bisphosphatase Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P49872 PFKFB1 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 Bos taurus (Bovine) PR
P26285 PFKFB2 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 Bos taurus (Bovine) PR
P16118 PFKFB1 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 Homo sapiens (Human) PR
Q16877 PFKFB4 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 Homo sapiens (Human) PR
Q16875 PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 Homo sapiens (Human) PR
P70266 Pfkfb1 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 Mus musculus (Mouse) PR
Q6DTY7 Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 Mus musculus (Mouse) PR
P70265 Pfkfb2 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 Mus musculus (Mouse) PR
O35552 Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 Rattus norvegicus (Rat) PR
P07953 Pfkfb1 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 Rattus norvegicus (Rat) PR
P25114 Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 Rattus norvegicus (Rat) PR
Q9JJH5 Pfkfb2 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MSGASSSEQN NNSYETKTPN LRMSEKKCSW ASYMTNSPTL IVMIGLPARG KTYVSKKLTR
70 80 90 100 110 120
YLNWIGVPTK VFNLGVYRRE AVKSYKSYDF FRHDNEEAMK IRKQCALVAL EDVKAYLTEE
130 140 150 160 170 180
NGQIAVFDAT NTTRERRDMI LNFAEQNSFK VFFVESVCDD PDVIAANILE VKVSSPDYPE
190 200 210 220 230 240
RNRENVMEDF LKRIECYKVT YRPLDPDNYD KDLSFIKVIN VGQRFLVNRV QDYIQSKIVY
250 260 270 280 290 300
YLMNIHVQPR TIYLCRHGES EFNLLGKIGG DSGLSVRGKQ FAQALRKFLE EQEITDLKVW
310 320 330 340 350 360
TSQLKRTIQT AESLGVPYEQ WKILNEIDAG VCEEMTYAEI EKRYPEEFAL RDQEKYLYRY
370 380 390 400 410 420
PGGESYQDLV QRLEPVIMEL ERQGNVLVIS HQAVMRCLLA YFLDKGADEL PYLRCPLHTI
430 440 450 460 470 480
FKLTPVAYGC KVETIKLNVE AVNTHRDKPT NNFPKNQTPV RMRRNSFTPL SSSNTIRRPR
490 500
NYSVGSRPLK PLSPLRAQDM QEGAD